Total Payments
$49,772
2024 Payments
$4,276
Companies
79
Transactions
1,970
Medicare Patients
5,844
Medicare Billing
$715,854
Payment Breakdown by Category
Food & Beverage$28,723 (57.7%)
Other$12,195 (24.5%)
Consulting$7,550 (15.2%)
Travel$1,108 (2.2%)
Education$196.79 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,723 | 1,933 | 57.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $12,175 | 9 | 24.5% |
| Consulting Fee | $7,550 | 5 | 15.2% |
| Travel and Lodging | $1,108 | 5 | 2.2% |
| Education | $196.79 | 17 | 0.4% |
| Long term medical supply or device loan | $19.98 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $14,122 | 87 | $0 (2024) |
| Amgen Inc. | $9,148 | 166 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,622 | 125 | $0 (2024) |
| ABBVIE INC. | $2,389 | 161 | $0 (2024) |
| Novo Nordisk Inc | $2,154 | 178 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,822 | 107 | $0 (2024) |
| PFIZER INC. | $1,463 | 136 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $1,381 | 18 | $0 (2021) |
| Allergan, Inc. | $1,333 | 114 | $0 (2020) |
| Lilly USA, LLC | $1,160 | 78 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,276 | 236 | AIMMUNE THERAPEUTICS, INC. ($406.11) |
| 2023 | $3,467 | 204 | ABBVIE INC. ($376.72) |
| 2022 | $3,420 | 219 | Novo Nordisk Inc ($652.98) |
| 2021 | $4,469 | 237 | Biohaven Pharmaceuticals, Inc. ($1,381) |
| 2020 | $3,562 | 189 | E.R. Squibb & Sons, L.L.C. ($1,525) |
| 2019 | $4,844 | 273 | E.R. Squibb & Sons, L.L.C. ($1,759) |
| 2018 | $16,079 | 334 | Amgen Inc. ($7,510) |
| 2017 | $9,655 | 278 | E.R. Squibb & Sons, L.L.C. ($5,630) |
All Payment Transactions
1,970 individual payment records from CMS Open Payments — Page 1 of 79
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.98 | General |
| Category: PAIN | ||||||
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $31.32 | General |
| Category: Cardio-renal | ||||||
| 12/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/17/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/14/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $7.93 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/12/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $7.73 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Respiratory | ||||||
| 12/10/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/09/2024 | Lucid Diagnostics Inc. | — | Food and Beverage | In-kind items and services | $16.59 | General |
| 12/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $26.08 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $4.24 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.80 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/26/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/26/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,533 | 2,680 | $434,523 | $187,214 |
| 2022 | 18 | 1,564 | 2,747 | $463,995 | $196,310 |
| 2021 | 23 | 1,592 | 2,513 | $427,498 | $193,633 |
| 2020 | 20 | 1,155 | 2,008 | $356,491 | $138,696 |
Total Patients
5,844
Total Services
9,948
Medicare Billing
$715,854
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 311 | 683 | $135,234 | $65,502 | 48.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 238 | 238 | $66,640 | $32,462 | 48.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 232 | $60,320 | $22,993 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 297 | 322 | $43,186 | $20,309 | 47.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 55 | 65 | $17,355 | $9,714 | 56.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 25 | 26 | $11,700 | $5,980 | 51.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 38 | $14,706 | $5,634 | 38.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 43 | 56 | $14,392 | $5,339 | 37.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 40 | $12,120 | $4,252 | 35.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $5,320 | $3,348 | 62.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 84 | 313 | $14,398 | $3,236 | 22.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 17 | 17 | $5,134 | $2,989 | 58.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 168 | 174 | $19,140 | $1,827 | 9.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 25 | 27 | $4,968 | $1,668 | 33.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 19 | $3,154 | $1,286 | 40.8% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 15 | 15 | $1,500 | $273.84 | 18.3% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 59 | 241 | $2,651 | $250.76 | 9.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 28 | 130 | $2,080 | $97.74 | 4.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 22 | 25 | $525.00 | $55.00 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 355 | 746 | $147,708 | $70,175 | 47.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 230 | 230 | $64,400 | $32,253 | 50.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 58 | 281 | $73,060 | $24,021 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 273 | 306 | $40,698 | $17,684 | 43.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 82 | 97 | $25,899 | $13,163 | 50.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 44 | 49 | $22,050 | $11,495 | 52.1% |
About Dr. John Panozzo, M.D
Dr. John Panozzo, M.D is a Family Medicine healthcare provider based in Orland Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841238029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Panozzo, M.D has received a total of $49,772 in payments from pharmaceutical and medical device companies, with $4,276 received in 2024. These payments were reported across 1,970 transactions from 79 companies. The most common payment nature is "Food and Beverage" ($28,723).
As a Medicare-enrolled provider, Panozzo has provided services to 5,844 Medicare beneficiaries, totaling 9,948 services with total Medicare billing of $715,854. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Orland Park, IL
- Active Since 06/02/2006
- Last Updated 09/13/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1841238029
Products in Payments
- ELIQUIS (Drug) $14,332
- Repatha (Biological) $7,464
- JARDIANCE (Drug) $1,969
- NURTEC ODT (Drug) $1,819
- UBRELVY (Drug) $1,425
- VRAYLAR (Drug) $893.50
- XARELTO (Drug) $886.24
- BREZTRI (Drug) $705.72
- REXULTI (Drug) $674.90
- ENTRESTO (Drug) $659.28
- FARXIGA (Drug) $579.43
- Ozempic (Drug) $571.01
- EVENITY (Biological) $563.37
- NEXLETOL (Drug) $553.54
- XIFAXAN (Drug) $549.12
- Horizant (Drug) $491.98
- CHANTIX (Drug) $478.38
- TRELEGY ELLIPTA (Drug) $473.44
- Otezla (Drug) $447.41
- Tresiba (Drug) $445.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Orland Park
Susan Rife, Do, DO
Family Medicine — Payments: $22,211
Family Medicine $22,211
Dr. Robert Wrona, D.o, D.O
Family Medicine — Payments: $18,307
Family Medicine $18,307
Dr. Susan Marcotte, D.o, D.O
Family Medicine — Payments: $12,219
Family Medicine $12,219
Hugh Oneill, Md, MD
Family Medicine — Payments: $8,957
Family Medicine $8,957
Dr. Linda Evans Beckman, Md, MD
Family Medicine — Payments: $7,143
Family Medicine $7,143
Dr. James Tess, M.d, M.D
Family Medicine — Payments: $5,776
Family Medicine $5,776